Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginger Powder Capsules for Endodontic Pain
NCT06439212Phase 3Not yet recruiting
- Sponsor
- Cairo University
- Start
- Jun 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ginger powder capsule in irreversible pulpitis (2 arms), sponsored by Cairo University. Primary endpoint: Postoperative pain at 48 hours. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
ginger powder capsule
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT06439212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06439212.